Salicylate-Derived Drug SANA may Promote Weight Loss Through Creatine Thermogenesis

A first-in-class compound shows promise in activating fat-burning pathways independently of GLP-1 and UCP1

Topline

SANA, a nitroalkene derivative of salicylate, activates creatine-dependent thermogenesis in fat tissue, reduces insulin resistance, and promotes weight loss, with early-phase clinical trials showing good safety and tolerability.

Study Details

Obesity and metabolic syndrome continue to strain healthcare systems despite major advances like GLP-1 agon…